Oxidative phosphorylation is a metabolic vulnerability of endocrine therapy and palbociclib resistant metastatic breast cancersRania El Botty, Elisabetta Marangoni|Nature Communications|2023Cited by 96
Pentraxin-3 is a PI3K signaling target that promotes stem cell–like traits in basal-like breast cancersClémence Thomas, Antoine E. Karnoub, Whitney S. Henry et al.|Science Signaling|2017Cited by 52
Inhibiting Aurora Kinases Reduces Tumor Growth and Suppresses Tumor Recurrence after Chemotherapy in Patient-Derived Triple-Negative Breast Cancer XenograftsAngela Romanelli, Elisabetta Marangoni|Molecular Cancer Therapeutics|2012Cited by 45
Establishment and characterisation of a new breast cancer xenograft obtained from a woman carrying a germline BRCA2 mutationLudmilla de Plater, Elisabetta Marangoni|British Journal of Cancer|2010Cited by 44
The impact of tumor epithelial and microenvironmental heterogeneity on treatment responses in HER2+ breast cancerMichalina Janiszewska, Kornélia Polyák, Shayna Stein et al.|JCI Insight|2021Cited by 42